Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Oxford Bioscience Partners · Boston, MA United States

Company Description

222 Berkeley St. Ste. 1650
Boston, MA
02116
United States (Map)
Phone: 617-357-7474
Fax: 617-357-7476
    View Oxford Bioscience Partners Locations On A US MapThis link will open in a new window
    A British accent is not required at Oxford Bioscience Partners (OBP). The venture capital firm invests in biotech and health care companies at all stages of development, but it specializes in seed and early-stage enterprises. OBP typically invests between $1 million to $10 million per transaction and provides assistance to its portfolio companies by taking seats on their boards of directors, recruiting executives, and facilitating corporate partnerships. The company targets firms that utilize information technology or genomics to discover and develop new drug therapies, medical devices, research and development equipment, and other products. To read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Oxford Bioscience Partners Financials

    Company TypePrivate

    Headquarters
    Fiscal Year-EndDecember
    Employees41

    Oxford Bioscience Partners Executives

    11 executives listed for Oxford Bioscience Partners's Boston, MA location.
    TitleName & BioContact
    Managing General PartnerJonathan FlemingNetwork
    CFORaymond CharestNetwork
    VP FinanceAlexia PearsallNetwork

    Competition

    Competitive Landscape for Oxford Bioscience Partners
    Demand is driven primarily by the pace of technological innovation and the number of companies created to commercialize new technologies. The profitability of individual companies depends on successfully choosing and managing a portfolio of investments. Large companies have advantages in attracting investors, developing expertise in multiple technology markets, and funding large deals. Small companies can compete effectively by concentrating on specific market sectors or geographic areas. The average venture capital investment is about $8 million. Individual, or angel, investors, and large companies with strategic interests in early-stage companies are also sources of new venture funding. To read the full description, subscribe now.
    Top Oxford Bioscience Partners Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!